Cargando…

In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal

Food-drug interaction is an infrequently considered aspect in clinical practice. Usually, drugs are taken together with meals and what follows may adversely affect pharmacokinetic and pharmacodynamic properties, and hence, the therapeutic effects. In this study, a computational protocol was proposed...

Descripción completa

Detalles Bibliográficos
Autores principales: Maruca, Annalisa, Lupia, Antonio, Rocca, Roberta, Keszthelyi, Daniel, Corsetti, Maura, Alcaro, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731208/
https://www.ncbi.nlm.nih.gov/pubmed/33266221
http://dx.doi.org/10.3390/ijms21239127
_version_ 1783621853482319872
author Maruca, Annalisa
Lupia, Antonio
Rocca, Roberta
Keszthelyi, Daniel
Corsetti, Maura
Alcaro, Stefano
author_facet Maruca, Annalisa
Lupia, Antonio
Rocca, Roberta
Keszthelyi, Daniel
Corsetti, Maura
Alcaro, Stefano
author_sort Maruca, Annalisa
collection PubMed
description Food-drug interaction is an infrequently considered aspect in clinical practice. Usually, drugs are taken together with meals and what follows may adversely affect pharmacokinetic and pharmacodynamic properties, and hence, the therapeutic effects. In this study, a computational protocol was proposed to explain the different assimilations of two µ-receptors agonists, eluxadoline and loperamide, with a peculiar pharmacokinetic profile. Compared to loperamide, eluxadoline is absorbed less after the intake of a fatty meal, and the LogP values do not explain this event. Firstly, keeping in mind the different pH in the intestinal tract, the protonation states of both compounds were calculated. Then, all structures were subjected to a conformational search by using MonteCarlo and Molecular Dynamics methods, with solvation terms mimicking the water and weak polar solvent (octanol). Both computational results showed that eluxadoline has less conformational freedom in octanol, unlike loperamide, which exhibits constant behavior in both solvents. Therefore, we hypothesize that fatty meal causes the “closure” of the eluxadoline molecule to prevent the exposure of the polar groups and their interaction with water, necessary for the drug absorption. Based on our results, this work could be a reasonable “case study”, useful for future investigation of the drug pharmacokinetic profile.
format Online
Article
Text
id pubmed-7731208
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77312082020-12-12 In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal Maruca, Annalisa Lupia, Antonio Rocca, Roberta Keszthelyi, Daniel Corsetti, Maura Alcaro, Stefano Int J Mol Sci Article Food-drug interaction is an infrequently considered aspect in clinical practice. Usually, drugs are taken together with meals and what follows may adversely affect pharmacokinetic and pharmacodynamic properties, and hence, the therapeutic effects. In this study, a computational protocol was proposed to explain the different assimilations of two µ-receptors agonists, eluxadoline and loperamide, with a peculiar pharmacokinetic profile. Compared to loperamide, eluxadoline is absorbed less after the intake of a fatty meal, and the LogP values do not explain this event. Firstly, keeping in mind the different pH in the intestinal tract, the protonation states of both compounds were calculated. Then, all structures were subjected to a conformational search by using MonteCarlo and Molecular Dynamics methods, with solvation terms mimicking the water and weak polar solvent (octanol). Both computational results showed that eluxadoline has less conformational freedom in octanol, unlike loperamide, which exhibits constant behavior in both solvents. Therefore, we hypothesize that fatty meal causes the “closure” of the eluxadoline molecule to prevent the exposure of the polar groups and their interaction with water, necessary for the drug absorption. Based on our results, this work could be a reasonable “case study”, useful for future investigation of the drug pharmacokinetic profile. MDPI 2020-11-30 /pmc/articles/PMC7731208/ /pubmed/33266221 http://dx.doi.org/10.3390/ijms21239127 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Maruca, Annalisa
Lupia, Antonio
Rocca, Roberta
Keszthelyi, Daniel
Corsetti, Maura
Alcaro, Stefano
In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal
title In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal
title_full In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal
title_fullStr In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal
title_full_unstemmed In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal
title_short In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal
title_sort in silico food-drug interaction: a case study of eluxadoline and fatty meal
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731208/
https://www.ncbi.nlm.nih.gov/pubmed/33266221
http://dx.doi.org/10.3390/ijms21239127
work_keys_str_mv AT marucaannalisa insilicofooddruginteractionacasestudyofeluxadolineandfattymeal
AT lupiaantonio insilicofooddruginteractionacasestudyofeluxadolineandfattymeal
AT roccaroberta insilicofooddruginteractionacasestudyofeluxadolineandfattymeal
AT keszthelyidaniel insilicofooddruginteractionacasestudyofeluxadolineandfattymeal
AT corsettimaura insilicofooddruginteractionacasestudyofeluxadolineandfattymeal
AT alcarostefano insilicofooddruginteractionacasestudyofeluxadolineandfattymeal